Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.
Yarrow is developing a first-in-class antibody targeting TSHR for the treatment of Graves’ disease and thyroid eye disease.
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.
Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.
Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.
Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.
Sermonix Pharmaceuticals is an Ohio LLC specialty pharmaceutical.
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
TELA Bio is a life science company that specializes in soft tissue reconstruction.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.
Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.
Perceptive Advisors has invested in 224 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Perceptive Advisors's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Medical. The firm invests across 16 different industry categories.
Among tracked funding rounds, Cerevel Therapeutics received $450.0M in a Post-IPO Equity round. Perceptive Advisors's total known invested capital is $26.6B.
Perceptive Advisors's average investment size is $135.1M across its portfolio of 224 companies.
Recent Perceptive Advisors portfolio additions include Crescent Biopharma, SpringWorks Therapeutics, Athira Pharma, Yarrow, Mythic Therapeutics. These companies were founded in 2020 or later.